Forte Biosciences Ownership | Who Owns Forte Biosciences?
Forte Biosciences Ownership Summary
Forte Biosciences is owned by 41.38% institutional investors, 10.96% insiders, and 47.66% retail investors. Fred alger management is the largest institutional shareholder, holding 14.20% of FBRX shares. Federated Hermes Kaufmann R is the top mutual fund, with 5.14% of its assets in Forte Biosciences shares.
FBRX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Forte Biosciences | 41.38% | 10.96% | 47.66% |
Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fred alger management | 1.62M | 14.20% | $20.93M |
Orbimed advisors | 1.20M | 10.50% | $15.48M |
Tybourne capital management (hk) | 786.65K | 6.90% | $10.17M |
Bvf inc/il | 588.34K | 5.16% | $7.61M |
Cable car capital | 500.00K | 4.39% | $6.46M |
Sphera funds management | 495.11K | 4.34% | $6.40M |
Ikarian capital | 476.44K | 4.18% | $6.16M |
Adage capital partners gp | 333.33K | 2.92% | $4.31M |
Heights capital management | 143.03K | 1.25% | $1.85M |
Geode capital management | 346.29K | 0.75% | $186.01K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Tybourne capital management (hk) | 786.65K | 29.45% | $10.17M |
Cable car capital | 500.00K | 2.07% | $6.46M |
Sphera funds management | 495.11K | 1.50% | $6.40M |
Ikarian capital | 476.44K | 1.18% | $6.16M |
Heights capital management | 143.03K | 0.49% | $1.85M |
Orbimed advisors | 1.20M | 0.39% | $15.48M |
Bvf inc/il | 588.34K | 0.27% | $7.61M |
Fred alger management | 1.62M | 0.09% | $20.93M |
Perceptive advisors | 68.19K | 0.03% | $881.72K |
Quest partners | 16.90K | 0.02% | $218.48K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Fred alger management | 1.62M | 0.09% | 708.04K |
Orbimed advisors | 1.20M | 0.39% | 603.87K |
Sphera funds management | 495.11K | 1.50% | 495.11K |
Adage capital partners gp | 333.33K | 0.01% | 333.33K |
Cable car capital | 500.00K | 2.07% | 280.40K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bml capital management | - | - | -1.76M |
Vanguard group | - | - | -665.23K |
Adar1 capital management | - | - | -159.26K |
Renaissance | - | - | -133.40K |
Ikarian capital | 476.44K | 1.18% | -132.78K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Sphera funds management | 495.11K | 1.50% | 495.11K | $6.40M |
Adage capital partners gp | 333.33K | 0.01% | 333.33K | $4.31M |
Heights capital management | 143.03K | 0.49% | 143.03K | $1.85M |
Susquehanna group, llp | 34.34K | - | 34.34K | $18.44K |
Envestnet asset management | 18.86K | 0.00% | 18.86K | $243.81K |
Sold Out
Holder | Change |
---|---|
Jpmorgan chase | -3.00 |
Qube research | -3.00 |
Fmr | -128.00 |
Loring wolcott & coolidge fiduciary advisors llp/ma | -193.00 |
Wells fargo & company/mn | -253.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 33 | 3.13% | 19,068,395 | 0.10% | 41 | 1.14% | 10 | 42.86% | 6 | 20.00% |
Mar 31, 2024 | 32 | -8.57% | 19,048,537 | 0.98% | 60 | 2.43% | 7 | -30.00% | 5 | - |
Dec 31, 2023 | 35 | 9.38% | 18,863,225 | 12.96% | 49 | 0.79% | 10 | -28.57% | 5 | -28.57% |
Sep 30, 2023 | 32 | 3.23% | 16,699,693 | 381.91% | 79 | 29.16% | 14 | 27.27% | 7 | -12.50% |
Jun 30, 2023 | 31 | 3.33% | 3,465,339 | -10.35% | 16 | 4.87% | 11 | 37.50% | 8 | -11.11% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Federated Hermes Kaufmann R | 628.21K | 5.14% | 628.21K |
Federated Hermes Kaufmann Growth | 628.21K | 5.14% | 628.21K |
Federated Hermes Kaufmann Small Cap A | 426.49K | 3.49% | 426.49K |
Federated Hermes Kaufmann Small Cap Grow | 426.49K | 3.49% | 426.49K |
Vanguard Total Stock Mkt Idx Inv | 380.08K | 3.11% | 216.08K |
Alger LIfe Sciences Innovation Composite | 178.34K | 1.46% | -27.03K |
Alger Small Cap Focus I | 176.87K | 1.45% | 176.87K |
Alger Small Cap Focus Composite | 176.87K | 1.45% | 176.87K |
Alger Small Cap Growth B | 157.75K | 1.29% | - |
Alger Health Sciences A | 134.57K | 1.10% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 21, 2024 | Riley Antony A | CHIEF FINANCIAL OFFICER | Buy | $125.00K |
Dec 18, 2023 | Wagner Paul A. | See Remarks | Buy | $7.53K |
Dec 13, 2023 | Wagner Paul A. | See Remarks | Buy | $7.35K |
Dec 14, 2023 | Wagner Paul A. | See Remarks | Buy | $7.20K |
Dec 11, 2023 | Wagner Paul A. | See Remarks | Buy | $16.19K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | - |
2025 Q2 | - | - |
2025 Q1 | - | - |
2024 Q4 | 1 | - |
2024 Q3 | - | - |
FBRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools